Aliviane No-Ad Inc

“When the form 990 is complete, the cfo and ceo present it to the executive committee of the board for review, changes and approval.”

“The organization has a conflict of interest policy. The policy is based on disclosure by the individual or by observations of others. A portion of the policy is as follows: disclosure in the agency should be made to the chief executive officer (or if she or he is the one with the conflicts, then to the board chair), who shall bring the matter to the attention of the board or a duly constituted committee thereof. Disclosure involving directors should be made to the board chair, (of if she or he is the one with the conflicts, the to the board vice-chair) who shall bring these matters to the board or a duly constituted committee thereof. The board or a duly constituted committee thereof shall determine whether a conflict exists and in the case of an existing conflict, whether the contemplated transaction may be authorized as just, fair, and reasonable to aliviane, inc. The decision of the board or a duly constituted committee thereof on these matters will rest in their sole discretion, and their concern must be the welfare of aliviane, inc. And the advancement of its purpose. Confidentiality - each director, officer, and employee shall exercise care note to disclose confidential information acquired in connection with disclosures of conflicts of interest or potential conflicts, which might be adverse to the interests.”

“Aliviane, inc. Makes its governing documents, conflict of interest policy and financial statements available to the public through request to the executive director. In addition, basic financial statements are included in the annual report which is distributed to persons and agencies who are interested in or have business with aliviane and with the public on a yearly basis.”

“The compensations for ceo is determined by the board of directors using a market analysis to determine the pay.”

“The process for reviewing the audited financial statements by the organization is as follows: after the external auditing firm has conducted the audit and completed the draft statements they are submitted to the agency cfo and the ceo for review and discussion. Next, the completed statements are presented to the board of directors during the board meeting. At that time the board could accept the audit and/or discuss and ask for changes that will present a truer representation of aliviane's financial position within the approval of the independent auditing firm.”

“Description:lab testing total expenses:24128 program services:24128 management and general:fundraising:”

“Description:public awareness total expenses:85277 program services:73018 management and general:12259 fundraising:”

“Description:medication total expenses:95576 program services:95576 management and general:fundraising:”

“Description:postage total expenses:13765 program services:12120 management and general:1645 fundraising:”

“Description:other total expenses:304686 program services:223908 management and general:80778 fundraising:”

“Description:bad debt total expenses:220896 program services:management and general:220896 fundraising:”

“Description:related party transfer total expenses:1244024 program services:management and general:1244024 fundraising:”

“Description:overhead allocation total expenses:program services:2185777 management and general:-2185777 fundraising:”